KEGG   DRUG: Lunsekimig
Entry
D13054                      Drug                                   
Name
Lunsekimig (USAN/INN)
Formula
C3023H4618N856O1004S21
Exact mass
69647.0751
Mol weight
69689.56
Sequence
DVQLVESGGG VVQPGGSLRL SCAASGRTFS SYRMGWFRQA PGKEREFVAA LSGDGYSTYT
ANSVKGRFTI SRDNSKNTVY LQMNSLRPED TALYYCAAKL QYVSGWSYDY PYWGQGTLVT
VSSGGGGSGG GGSGGGGSGG GGSGGGGSGG GGSGGGGSEV QLVESGGGVV QPGGSLRLSC
AASGFTFNNY AMKWVRQAPG KGLEWVSSIT TGGGSTDYAD SVKGRFTISR DNSKNTLYLQ
MNSLRPEDTA LYYCANVPFG YYSEHFSGLS FDYRGQGTLV TVSSGGGGSG GGSEVQLVES
GGGVVQPGGS LRLSCAASGS GFGVNILYWY RQAAGIEREL IASITSGGIT NYVDSVKGRF
TISRDNSENT MYLQMNSLRA EDTGLYYCAS RNIFDGTTEW GQGTLVTVSS GGGGSGGGSE
VQLVESGGGV VQPGGSLRLS CAASGFTFRS FGMSWVRQAP GKGPEWVSSI SGSGSDTLYA
DSVKGRFTIS RDNSKNTLYL QMNSLRPEDT ALYYCTIGGS LSRSSQGTLV TVSSGGGGSG
GGSEVQLVES GGGVVQPGGS LRLSCAASGF TFADYDYDIG WFRQAPGKER EGVSCISNRD
GSTYYADSVK GRFTISRDNS KNTVYLQMNS LRPEDTALYY CAVEIHCDDY GVENFDFDPW
GQGTLVTVSS A
(Disulfide bridge: 22-96, 180-254, 315-388, 441-515, 565-641, 595-647)
  Type
Peptide
Efficacy
Antiasthmatic, Anti-inflammatory
  Type
Multispecific antibody
Comment
Treatment of asthma and inflammatory diseases
Target
IL13 [HSA:3596] [KO:K05435]
TSLP [HSA:85480] [KO:K05436]
ALB [HSA:213] [KO:K16141]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  JAK-STAT signaling pathway
hsa04658  Th1 and Th2 cell differentiation
hsa04664  Fc epsilon RI signaling pathway
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Interleukins
    IL13
     D13054  Lunsekimig (USAN/INN)
   CSF and other factors
    TSLP
     D13054  Lunsekimig (USAN/INN)
 Not elsewhere classified
  Organismal systems
   Circulatory system
    ALB
     D13054  Lunsekimig (USAN/INN)
Other DBs
CAS: 2770858-49-4
PubChem: 505917327
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system